Valentino MA, Lin JE, Waldman SA Central and Peripheral Molecular Targets for Anti-Obesity Pharmacotherapy Clinical Pharmacology & Therapeutics (2010) 3
Its vital to follow seven key medical guidelines for effective treatment
IV doses of 25-400 mcg/kg for safety studies Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, pharmacokinetics, receptor expression, peptide degradation rates, and tissue distribution patterns
Your baby may experience developmental delays and not grow properly due to B12 deficiency
16 weeks 112 syringes 1 syringe per day across 16 weeks
Anything higher than that quickly becomes too much volume for one subQ site, which is why oral capsules are the standard route